A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT04901195. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
Study identification
- NCT ID
- NCT04901195
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 658 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 27, 2021 (Actual)
- Primary completion
- Jul 22, 2026 (Actual)
- Completion
- Jul 22, 2026 (Actual)
- Last update posted
- Oct 6, 2026
2021 – 2026
United States locations
- U.S. sites
- 43
- U.S. states
- 26
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hs0005 50140 | Birmingham | Alabama | 35249 | — |
| Hs0005 50175 | Phoenix | Arizona | 85006 | — |
| Hs0005 50162 | Fountain Valley | California | 92708 | — |
| Hs0005 50161 | Los Angeles | California | 90045 | — |
| Hs0005 50220 | San Diego | California | 92123 | — |
| Hs0005 50196 | Thousand Oaks | California | 91320 | — |
| Hs0005 50199 | Miami | Florida | 33136 | — |
| Hs0005 50205 | North Miami Beach | Florida | 33162-4708 | — |
| Hs0005 50152 | Orange Park | Florida | 32073 | — |
| Hs0005 50184 | Pembroke Pines | Florida | 33028 | — |
| Hs0005 50193 | Sandy Springs | Georgia | 30329 | — |
| Hs0005 50280 | Watkinsville | Georgia | 30677 | — |
| Hs0005 50234 | Plainfield | Indiana | 46168 | — |
| Hs0005 50425 | Murray | Kentucky | 42071 | — |
| Hs0005 50198 | Beverly | Massachusetts | 01915 | — |
| Hs0005 50146 | Boston | Massachusetts | 02215 | — |
| Hs0005 50178 | Clarkston | Michigan | 48346 | — |
| Hs0005 50105 | St Louis | Missouri | 63110 | — |
| Hs0005 50194 | Omaha | Nebraska | 68144 | — |
| Hs0005 50208 | Las Vegas | Nevada | 89148 | — |
| Hs0005 50159 | Newington | New Hampshire | 03801 | — |
| Hs0005 50137 | East Windsor | New Jersey | 08520 | — |
| Hs0005 50200 | Verona | New Jersey | 07044 | — |
| Hs0005 50237 | Albuquerque | New Mexico | 87102 | — |
| Hs0005 50235 | New York | New York | 10003 | — |
| Hs0005 50151 | Chapel Hill | North Carolina | 27516 | — |
| Hs0005 50211 | Durham | North Carolina | 27710 | — |
| Hs0005 50179 | Winston-Salem | North Carolina | 27157 | — |
| Hs0005 50177 | Cincinnati | Ohio | 45219 | — |
| Hs0005 50138 | Columbus | Ohio | 43213 | — |
| Hs0005 50145 | Columbus | Ohio | 43230 | — |
| Hs0005 50202 | Fairborn | Ohio | 45324 | — |
| Hs0005 50204 | Tulsa | Oklahoma | 74137 | — |
| Hs0005 50147 | Hershey | Pennsylvania | 17033 | — |
| Hs0005 50008 | Johnston | Rhode Island | 02919 | — |
| Hs0005 50180 | Providence | Rhode Island | 02903 | — |
| Hs0005 50084 | Charleston | South Carolina | 29425 | — |
| Hs0005 50236 | Greenville | South Carolina | 29615 | — |
| Hs0005 50142 | Nashville | Tennessee | 37215 | — |
| Hs0005 50201 | Arlington | Texas | 76011 | — |
| Hs0005 50148 | Pflugerville | Texas | 78660 | — |
| Hs0005 50141 | Salt Lake City | Utah | 84107 | — |
| Hs0005 50270 | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04901195, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04901195 live on ClinicalTrials.gov.